Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7867905 | 0.84 | TSHR (0.40) | ALDH1A1TSHRHPGD | |
| Ethylene SCHEMBL8007277 | 0.83 | ALDH1A1 (0.39) | ALDH1A1 | |
| Ethylene SCHEMBL8007273 | 0.83 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL8512429 | 0.83 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL29832859 | 0.83 | ALDH1A1 (0.37) | ALDH1A1 | |
| Acrylic Acid Ethyl Ester SCHEMBL10672146 | 0.82 | ALDH1A1 (0.61) | ALDH1A1TSHRHPGD | |
| Propene SCHEMBL3980483 | 0.82 | ALDH1A1 (0.40) | ALDH1A1 | |
| Acrylic Acid Ethyl Ester SCHEMBL2431230 | 0.82 | TSHR (0.46) | ALDH1A1TSHRHPGDHCAR2 | |
| Acrylic Acid SCHEMBL28225132 | 0.80 | ALDH1A1 (0.39) | ALDH1A1 | |
| Ethylene SCHEMBL4370792 | 0.79 | ALDH1A1 (0.42) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1591097-B1 | Cationically curing two component materials containing a noble metal catalyst | MINNESOTA MINING MFG GMBH (DE) | 2012-06-20 | — | — | EP | disclosed |
| US-7368524-B2 | Cationically curing two component materials containing a noble metal catalyst | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-05-06 | — | — | US | disclosed |
| US-20060116445-A1 | Cationically curing two component materials containing a noble metal catalyst | 3M DEUTSCHLAND GMBH (DE) | 2006-06-01 | — | — | US | disclosed |
| EP-1591097-A1 | Cationically curing two component materials containing a noble metal catalyst | 3M Espe AG (DE) | 2005-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060116445-A1 | Cationically curing two component materials containing a noble metal catalyst | CAD, ELL, MEP1A | ALDH1A1 2908/4885TSHR 4837/4885HPGD 636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.